~~<i id='37F3E8F703'><strike id='37F3E8F703'><tt id='37F3E8F703'><pre id='37F3E8F703'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：entertainment 2025-09-29 21:28:03 - browse：6978

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Humana, CVS hope to turn members into patients at clinics

hotspot

leisure time

hotspot

leisure time

focus

0:25AMegaMillionswageringslipisheldinCranberryTownship,Pa.,Jan.12,2023.GeneJ.Puskar/AP,FileTheMegaMi

WSS

Why failed clinical trials don’t always spell doom for a new drug

Emergent cuts jobs, executive role in business shake

Anavex keeps shifting the goalposts in its clinical trials

What Mike Pence has said that could be used in a Donald Trump trial

Wegovy trial has doctors encouraged over new possibilities

Attacks on the drug industry will lead to fewer breakthroughs

leisure time

focus

hotspot

At least 13 dead in Texas as scorching temps continue

How to use technology to prevent future drug shortages

Drug repurposing or repositioning? The language matters

Microsoft strikes partnership with Duke Health to advance health AI

Hollywood unions extend contract negotiations for actors

Friends ask where James Watson's attitudes about race came from

State Dept. review finds Biden bears some blame for Afghanistan failures

Methadone doses haven’t kept up in the age of fentanyl

Apple is now the first public company to be valued at $3 trillion

American woman, child freed after being kidnapped in Haiti last month

leisure time

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

TytoCare raises $49 million to build out AI

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Emergent cuts jobs, executive role in business shake

In same hospitals, Black patients receive fewer opioids than white patients

hotspot

hotspot

leisure time

focus